On March 15, 2024, the Board of Directors of Co-Diagnostics, Inc. appointed Richard Abbott as President. Prior to being appointed as President, from January 2021 to March 2024, Mr. Abbott, age 52, served as President of Advanced Conceptions, Inc., a wholly owned subsidiary of Co-Diagnostics, Inc., a privately held medical device company focused on the design of automated instruments that solve challenging cross-disciplinary problems. From September 2018 to January 2021, Mr. Abbott was a partner in SaltRidge, LLC through which he provided management services to Advanced Conceptions and other consulting services. From August 2017 to August 2018, he served as the Chief Technology Officer for privately held Vilicus, a cloud centered network provider of IoT devices for indoor agriculture.

From October 2016 to July 2017, Mr. Abbott served as the Chief Technology Officer for Fenome, a private company focused on the manipulation of phenotypic expression of indoor agriculture crops via environmental control during growth and fruiting. Mr. Abbott holds a Master of Business Administration from The Wharton School and a Master of Science, Mechanical Engineering and a Bachelors Mechanical Engineering from Brigham Young University.